Clinical trials
Phase 1 Hepatic Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 12 |
| Eli Lilly and Company | 12 |
| Merck Sharp & Dohme LLC | 10 |
| Pfizer | 5 |
| Bristol-Myers Squibb | 4 |
| Bayer | 3 |
| Acerta Pharma BV | 2 |
| Ahon Pharmaceutical Co., Ltd. | 2 |
| Incyte Corporation | 2 |
| Allergan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatic Insufficiency | 77 |
| Liver Diseases | 10 |
| Lymphoma, Follicular | 4 |
| Renal Insufficiency | 3 |
| Liver Cirrhosis | 2 |
| Biliary Atresia | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Fibrosis | 1 |
| Heart Failure | 1 |
Trials
Showing 76 to 77 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.